135 related articles for article (PubMed ID: 12651278)
1. Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia.
Schoch C; Schnittger S; Kern W; Dugas M; Hiddemann W; Haferlach T
Haematologica; 2003 Mar; 88(3):351-2. PubMed ID: 12651278
[No Abstract] [Full Text] [Related]
2. Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival.
Arber DA; Stein AS; Carter NH; Ikle D; Forman SJ; Slovak ML
Am J Clin Pathol; 2003 May; 119(5):672-80. PubMed ID: 12760285
[TBL] [Abstract][Full Text] [Related]
3. [Haematological characteristics, FAB and WHO classification of 153 cases of myeloid acute leukaemia in Tunisia].
Braham-Jmili N; Sendi-Senana H; Labiadh S; Ben Abdelali R; Ben Abdelaziz A; Khelif A; Saad A; Kortas M
Ann Biol Clin (Paris); 2006; 64(5):457-65. PubMed ID: 17040877
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia.
Heerema-McKenney A; Arber DA
Hematol Oncol Clin North Am; 2009 Aug; 23(4):633-54. PubMed ID: 19577162
[TBL] [Abstract][Full Text] [Related]
5. NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia.
Falini B; Mecucci C; Saglio G; Lo Coco F; Diverio D; Brown P; Pane F; Mancini M; Martelli MP; Pileri S; Haferlach T; Haferlach C; Schnittger S
Haematologica; 2008 Mar; 93(3):439-42. PubMed ID: 18268276
[TBL] [Abstract][Full Text] [Related]
6. Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients.
Bacher U; Kern W; Schnittger S; Hiddemann W; Schoch C; Haferlach T
Ann Hematol; 2005 Nov; 84(12):785-91. PubMed ID: 16132906
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes for unselected patients with acute myeloid leukemia categorized according to the World Health Organization classification: a single-center experience.
Yanada M; Suzuki M; Kawashima K; Kiyoi H; Kinoshita T; Emi N; Saito H; Naoe T
Eur J Haematol; 2005 May; 74(5):418-23. PubMed ID: 15813916
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and cytogenetics studies on acute myeloid leukemia with abnormality of chromosome 11].
Lu Y; Xu W; Chen Z; Lou J; Jin J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):583-5. PubMed ID: 18841578
[TBL] [Abstract][Full Text] [Related]
9. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
[TBL] [Abstract][Full Text] [Related]
10. Frequency of fab subtypes in acute myeloid leukemia patients at Aga Khan University Hospital Karachi.
Harani MS; Adil SN; Shaikh MU; Kakepoto GN; Khurshid M
J Ayub Med Coll Abbottabad; 2005; 17(1):26-9. PubMed ID: 15929522
[TBL] [Abstract][Full Text] [Related]
11. Realistic pathologic classification of acute myeloid leukemias.
Arber DA
Am J Clin Pathol; 2001 Apr; 115(4):552-60. PubMed ID: 11293903
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic and morphological findings in 166 patients with de novo acute myeloid leukemia in southern Brazil.
Onsten T; Girardi FM; Coelho GM; Lima Frey MC; Paskulin G
Cancer Genet Cytogenet; 2006 Oct; 170(2):167-70. PubMed ID: 17011990
[TBL] [Abstract][Full Text] [Related]
13. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
Larson RA; Le Beau MM
Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization.
Klaus M; Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C
Cancer Genet Cytogenet; 2004 Nov; 155(1):47-56. PubMed ID: 15527902
[TBL] [Abstract][Full Text] [Related]
15. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups.
Schoch C; Kern W; Schnittger S; Büchner T; Hiddemann W; Haferlach T
Haematologica; 2004 Sep; 89(9):1082-90. PubMed ID: 15377469
[TBL] [Abstract][Full Text] [Related]
16. [Significance of WHO classification for acute leukemia and myelodysplastic syndrome].
Sugiura A; Takeshita A
Rinsho Byori; 2006 Nov; 54(11):1178-86. PubMed ID: 17240841
[TBL] [Abstract][Full Text] [Related]
17. Chromosome aberrations in de novo acute myeloid leukemia patients in Kuwait.
Al Bahar S; Pandita R; Bavishi K; Kreze O; Nath S
Neoplasma; 2004; 51(3):223-7. PubMed ID: 15254677
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study of 572 adult acute leukemia patients in Shanghai according to WHO classification].
Sino US Leukemia Cooperative Group of Shanghai
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):444-8. PubMed ID: 18072625
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of myeloid hematologic malignancies: contributions of the 2001 World Health Organization (WHO) classification].
Leymarie V; Galoisy AC; Falkenrodt A; Lessard M
Ann Biol Clin (Paris); 2004; 62(5):513-20. PubMed ID: 15355801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
